Skip to main content
IRIX logo

IRIX

Iridex Corp
$1.10 -0.02 (-1.79%) At close · Jul 10
Market Cap
$19.32M
Shares
17,406,518

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$52.68M
FY2026 Revenue FY2011–FY2026
Net Income
-$4.44M
FY2026 Net Income FY2011–FY2026
Gross Margin
36.5%
FY2026 Gross Margin FY2011–FY2026
Operating Margin
-4.88%
FY2026 Operating Margin FY2011–FY2026
Diluted EPS
-$0.26
FY2026 Diluted EPS FY2012–FY2026
Operating Cash Flow
-$2.12M
FY2026 Operating Cash Flow FY2011–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2026 FY2024 FY2023 FY2022 FY2021 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
$52.58M $52.68M $48.67M $51.87M $56.97M $53.9M $43.45M $42.6M $41.59M $46.16M $41.76M $42.81M $38.27M $33.86M $33.16M
$33.67M $33.45M $29.17M $30.06M $31.6M $31.07M $25.51M $25.13M $26.09M $25.32M $21.8M $21.41M $19.69M $17.51M $16.87M
$18.91M $19.23M $19.5M $21.81M $25.37M $22.83M $17.94M $17.47M $15.5M $20.84M $19.95M $21.41M $18.59M $16.35M $16.29M
36.5% 40.07% 42.04% 44.53% 42.36% 41.29% 41.01% 37.27% 45.15% 47.78% 50% 48.56% 48.28% 49.13%
$3.7M $3.67M $5.45M $6.83M $7.18M $6.87M $3.68M $4.01M $5.73M $5.37M $5.21M $4.63M $3.68M $4.39M $3.91M
$10.48M $10.4M $12.58M $16.24M $18.18M $14.64M $14.85M $16.78M $14.54M $10.28M $8.9M $8.16M $7.72M $7.9M $7.46M
$7.43M $7.73M $9.78M $8.75M $7.56M $8.86M $8.38M $9.55M $8.26M $7.64M $5.55M $6.03M $5.02M $4.93M $4.26M
$323K $333K $333K $228K $163K $16K $16K $16K $16K $16K $44K $226K $191K
$523K $584K $1.1M $485K $803K $688K $809K $858K $648K $522K $420K $490K $427K $410K
$21.6M $21.8M $27.8M $31.81M $32.91M $30.36M $26.91M $30.34M $28.39M $23.4M $19.67M $18.82M $15.95M $17.21M $14.36M
-$2.69M -$2.57M -$8.3M -$10.01M -$7.54M -$7.53M -$8.97M -$12.87M -$12.89M -$2.57M $288K $2.59M $2.63M -$860K $1.93M
-4.88% -17.06% -19.29% -13.24% -13.98% -20.66% -30.21% -30.99% -5.56% 0.69% 6.04% 6.88% -2.54% 5.83%
-$2.05M -$7.72M -$8.91M -$7.06M -$6.73M -$8.29M -$12.06M -$12.03M -$1.92M $810K $3.01M $3.12M -$433K $2.34M
-$482K -$1.81M -$540K $527K $60K $2.35M $209K $92K -$107K -$91K $3000 $504K
-$3.17M -$4.38M -$8.84M -$9.48M -$7.48M -$5.19M -$8.77M -$12.78M -$13M -$2.66M $291K $1.33M $2.26M -$270K $2.44M
$103K $57K $68K $90K $65K $40K $48K $37K -$128K $9.06M -$183K -$8.71M $31K -$100K $297K
-$3.28M -$4.44M -$8.91M -$9.57M -$7.55M -$5.23M -$8.81M -$12.81M -$12.87M -$11.71M $474K $10.04M $2.23M $1.44M $2.61M
-8.42% -18.31% -18.45% -13.25% -9.69% -20.28% -30.08% -30.94% -25.38% 1.14% 23.45% 5.83% 4.25% 7.87%
-$3.31M -$4.5M -$8.81M -$9.6M -$7.62M -$5.16M -$8.8M -$12.74M -$12.87M -$11.71M $474K $10.04M $2.23M $1.47M $2.78M
USD/shares -$0.26 -$0.54 -$0.59 -$0.47 -$0.34 -$0.64 -$1.05 -$1.11 -$1.15 $0.05 $1.01 $0.24 $0.16
USD/shares -$0.26 -$0.54 -$0.59 -$0.47 -$0.34 -$0.64 -$1.05 -$1.11 -$1.15 $0.05 $0.97 $0.22 $0.16
shares 16.93M 16.44M 16.13M 15.94M 15.42M 13.71M 12.2M 11.56M 10.17M 9.96M 9.89M 9.25M 8.94M 8.96M
shares 16.93M 16.44M 16.13M 15.94M 15.42M 13.71M 12.2M 11.56M 10.17M 10.13M 10.36M 10.1M 8.94M 10.23M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2011–FY2017: $10.26M in buybacks.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
Medical Devices median 2.38×
EV/EBIT
Medical Devices median 21.54×
P/E (TTM)
Medical Devices median 26.84×

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Geography (USD)

Component 2026-01-03 2024-12-28 2023-12-30 2022-12-31 2022-01-01 2021-01-02
United States $23,210,000 $22,690,000 $26,054,000 $29,179,000 $24,946,000 $19,312,000
Europe Middle East and Africa $14,391,000 $11,824,000 $13,519,000 $13,801,000 $13,970,000
Asia Pacific $12,953,000 $11,950,000 $10,234,000 $10,931,000 $12,444,000 $7,062,000
Americas Excluding US $2,121,000 $2,205,000 $2,062,000 $3,061,000 $2,543,000 $1,967,000
Europe $8,006,000

By Product & Service (USD)

Component 2026-01-03 2024-12-28 2023-12-30 2022-12-31 2022-01-01 2021-01-02
Retina $30,280,000 $27,827,000 $29,445,000 $31,657,000 $31,106,000 $18,088,000
Cyclo G Six $13,843,000 $12,697,000 $13,461,000 $14,694,000 $13,950,000 $11,272,000
Product And Service Other $8,552,000 $8,145,000 $8,963,000 $10,621,000 $8,847,000 $6,987,000
Service $1,300 $1,400 $1,534,000 $1,509,000 $1,386,000 $1,263,000
Key facts CIK 1006045 CUSIP 462684101 Visit website Investor relations